We found that overexpression or knockdown of PHF19 could not influence the chemoresistance of HEY-T30 and SKOV3 to cisplatin (Figure S1), suggesting that the drug-resistance of ovarian cancer cells induced by PHF19 may be specific for CFG. The gene discussed is PHF19; the disease is ovarian cancer.